Current Topics
"Not Happy" Tree-of-Life Huggers Step up Diversity Sampling
In part because genomic sequencing is "biased" and thus not a "good sampling of diversity in genomes," the tree of life is "not happy," says Jonathan Eisen of the University of California, Davis (UCD). "We need more experiments across the tree of life, not just in model organisms. . . And, eventually, we want a field guide to microbial behavior and ecology."
Such grand ambitions for adding many, many more microbial twigs and branches to the tree of life seem a fitting tribute to the late Joshua Lederberg. While not one to shun the value in studying model microorganisms, it is easy to imagine him applauding current efforts to shake up, if not uproot, the tree of life by enormously expanding its genomic details. A generous sampling of those detailsoriented efforts went on display last May during "Microbial Evolution and Co-Adaptation: a Workshop in Honor of Joshua Lederberg," convened by the versatile Forum on Microbial Threats from the Institute of Medicine in Washington, D.C.
Phylogenomic analysis involves combing through genomic data, seeking clues as to how genetic changes lead to functional diversity and other novelties. In one approach, Eisen scrutinizes clusters of genes and their distribution patterns across microbial species-seeking, among other things, evidence for novel functions emerging as mutations accumulate within some of those clusters. For instance, Vibrio cholerae contains what seems to be a "massively expanded" set of MCP genes, which are part of the chemotaxis apparatus in Escherichia coli, he says. Assuming those genes would disappear if they were not being used, "they're still being around suggests at least some function, possibly novel."
Figuring out what those novel functions might be remains a "challenge," Eisen says. Meanwhile, a similar review of sporulation-related gene clusters led him to realize that a particular anaerobic species, previously not thought to form spores, indeed does so. In the process, he uncovered what appears to be "eight new sporulationrelated genes."
Microbial communities, including those within biofilms that form in exotic environments, also provide a fruitful means for uncovering the richness of both genetic and metabolic diversity, according to Jill Banfield of the University of California, Berkeley. Even when members of these microbial communities prove indistinguishable on the basis of their genetics, it may be possible to tell strains apart by slight differences among their proteins, she says. Amid this ongoing interplay among bacterial species and strains within biofilms, she adds, viruses "have great potential to shape microbial communities."
Moreover, despite many microorganisms carrying the genetically encoded Cas system that protects them against encroaching viruses and plasmids, apparently the "viral population is rapidly recombining to defeat this host-silencing system," Banfield says. One upshot is that viral and microbial cellular populations are "very heterogeneous," with "no two cells within a microbial community being identical." Thus, viruses and their mi-crobial hosts share "incredible heterogeneity"-another sign that the microbial end of the tree of life is rich with detail.
The human microbiota is also rich in diversity, albeit not so much in terms of phyla but more so in terms of species and strains, according to workshop participant David Relman of Stanford University in Stanford, Calif. Not surprisingly, this richness is "perturbed" when individuals undergo treatments with antibiotics. For example, ciprofloxacin treatment "decreases the richness and evenness of microbial diversity," he says. Bacteroides abundance then goes up in everyone tested so far, but in each individual a different species and strain changes more than others, he adds. "This microbial ecosystem may reflect who we are."
However, describing the role of that ecosystem in health, disease, and recovery remains a major challenge. Moreover, the same can be said for many of the specific microbial species that we designate pathogens, according to Stanley Falkow, also of Stanford University. He suggests that some pathogens are merely commensals that carry virulence factors and "live in dangerous places"-that is, anatomic sites-where they may "avoid competition." Thus, what are called "virulence" factors in one setting might pass as "colonizing" factors in another.
This blurring of terms is not restricted to the commensal-pathogen microbiota that associates with humans. Insects such as the cabbage white gypsy moth also provide habitats for commensal and pathogenic microorganisms, whose roles may be-come blurred under some circumstances, according to Jo Handelsman of the University of Wisconsin, Madison. For instance, when such moths are treated with antibiotics to knock out their gut microbiota, the "recovered community is more readily invaded than was the original," she says, "and that is the opposite of what's expected" based on ecological principles. Other experiments that involve additionally treating such moths with Bt toxin suggest that the gut bacteria themselves play a key role in making this toxin lethal to hosts, she points out. Bt toxin opens membrane pores, and the gut microbiota help to drive host-inflammatory responses that prove lethal-surely not a role that commensal microorganisms ordinarily play.
An important component to comprehending microbial diversity is "knowing what we don't know," says Eisen of UCD. Every indicator suggests there is plenty yet to learn. Moreover, judging from responses by other workshop participants to those remarks, he may well have been channeling Lederberg. Jeffrey L. Fox Jeffrey L. Fox is the Microbe Current Topics and Features Editor.
Screen Based on Genome Data Could Aid Vaccine Development
Even with genome sequence data in hand, identifying which antigens from a pathogen will stimulate a strong host-immune response and, thus, might be used for making a vaccine proves challenging. One new approach involves a rapid, highthroughput means for screening antigens to find those best recognized by host T cells, and it appears applicable to any microorganism, even those that require special handling, according to Wendy Brown and her collaborators at Washington State University (WSU) in Pullman. "You don't have to touch the organism, you just express the proteins and test them," she says. Brown and her collaborators are applying their strategy to Anaplasma marginale, a bacterial pathogen that is spread by ticks and which causes severe anemia in cattle. Although Anaplasma is the most common tickborne disease of cattle worldwide, there are no truly protective vaccines that are available commercially for preventing such infections. However, cattle can be immunized by injecting them with an experimental product that consists of an outer membrane fraction from the pathogen, according to Brown. Kelly Brayton from WSU and collaborators recently determined the genomic sequence of A. marginale and then compared their data to those of other microorganisms to identify genes encoding proteins along the A. marginale outer membrane that might serve as antigens by interacting with host immune cells. Starting with 50 such candidates, the WSU researchers then introduced them into Escherichia coli cells as transcriptionally active PCR (TAP) fragments.
The recombinant proteins derived from A. marginale were separated from bacterial host proteins, also made in the E. coli producer cells. The recombinant proteins were mixed with peripheral lymphocytes obtained from cows that earlier were immunized with Anaplasma outer membrane proteins, and subsequently were tested against memory CD4 ϩ T cells from cattle. The testing identified 23 proteins as immune stimulators, part of a group that included several major surface proteins, MSP2 and MSP3, as well as VirB9 and VirB10 belonging to the type IV secretion system. Additional immune-cell stimulators included the outer membrane proteins OMP4 and OMP9, elongation factor Tu, and Ana29. The WSU group is continuing to evaluate which of these several antigens will be best suited for a vaccine. Further details appear in the March 2008 issue of Journal of .
Two Unusual Hepatitis C Treatment Candidates Showing Promise
Two different and unusual candidate treatments for combating the hepatitis C virus (HCV) are showing progress, albeit in the very early stages of clinical trials. One of them, designated, SPC3649, was set to enter phase 1 clinical trials late in May and is being developed by Santaris Pharma of Copenhagen, Denmark. SPC3649 targets mi-croRNA-122, a small, liver-expressed, regulatory RNA molecule that facilitates HCV replication in liver cells. The trial marks the first time a microRNA drug is being tested in humans-first in uninfected volunteers, soon to be followed by individuals infected with HCV, according to Santaris. Meanwhile, another candidate treatment for individuals infected with HCV, Albuferon, a proprietary form of albumin-interferon alpha 2b, is being developed by Human Genome Sciences (HGS) of Rockville, Md. This long-acting form of interferon alpha is being developed for combined use with other antiviral agents to treat individuals with chronic hepatitis C. This past April, HGS reported completing the treatment phase in one of two Phase 3 trials in which Albuferon is being combined with ribavirin in such patients; data from these trials are expected late in 2008 and early in 2009. Brown credits Philip Felgner from the University of California, Irvine, for laying the groundwork for this antigen-screening approach. He designed a system for generating proteomes of microorganisms and then applying those unpurified proteins onto microarray chips where they can be exposed to serum from different host species to determine antibody responses (Proceedings of the National Academy of Sciences, January 18, 2005, p. 547-552) . "I adapted that technology to be able to stimulate T cells," Brown says.
"The same reagents needed to generate protein microarrays can be used in a high-throughput CD4 ϩ T cell assay," Felgner says. He and Brown share a common goal: Both want to apply their methods to obtain complete profiles of antigen-specific antibody or CD4 ϩ T cell responses that develop after a particular host species is exposed to a specific pathogen. "The data are relevant to serodiagnostics and vaccine antigen discovery," Felgner says.
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Carol Potera is a freelance writer in Great Falls, Mont. According to the report, researchers and physicians have long suspected that MAP could play a role in Crohn's disease because of its unambiguous role in causing Johne's disease in ruminants, a condition that shares many symptoms with Crohn's, including diarrhea, weight loss, and periods of remission. Physicians also note that treating Crohn's patients with antibiotics to target mycobacteria often provides relief from Crohn's symptoms. MAP conceivably is passed from livestock with Johne's disease to humans through contaminated meat and dairy products, providing a scenario for human exposure to the pathogen, according to the report.
Recent studies further strengthen the idea that MAP is tied to Crohn's disease, according to Carol Nacy of Sequella, Inc., in Rockville, Md., who chaired the colloquium. Nacy points out that MAP can be detected in the tissues of seven of eight patients suffering from Crohn's. "I think the association is no longer really in question," she says, but she cautions that finding the bacteria in such patients does not mean that MAP causes Crohn's, since it may be only incidentally present, taking advantage of the environment created by other pathogens or other factors.
Nacy also points out that several factors are probably responsible for causing Crohn's disease, and they may include underlying host genetic or immune factors in addition to one or more infectious agents. This complicated network of factors defies a simple explanation and has confounded efforts to understand this disease, according to Nacy. "It's not just being infected with a bacterium," she says. "It's many things combined together that create the environment that creates disease. And all of those factors need to be systematically sorted out by both basic and clinical research."
The AAM report identifies several major barriers to figuring out whether Anaplasma marginale, a bacterial pathogen that causes severe anemia and results in significant morbidity and mortality in cattle, is the target of a vaccine development effort. Another pathogen endemic in cattle, Mycobacterium avium subspecies paratuberculosis, may be the source of Crohn's disease in humans, according to a recent report from the American Academy of Microbiology. (Photo © David R. Frazier Photolibrary, Inc./Photo Researchers, Inc.) MAP plays a truly causative role in Crohn's and outlines a rigorous research agenda. "The whole point of the report is to highlight the research agenda that should be brought forward so that we can answer these questions once and for all," Nacy says.
The report separates research priorities into two general areas of emphasis-one being transmission of MAP from food and the environment to humans and the other being susceptibility of humans to MAP infection and disease. Among other key questions: Is MAP widely present in food, and does it colonize or infect humans who consume it? Also, what is a "normal" immunological response to MAP, and does that response differ in individuals who develop Crohn's?
Although research to address such questions is a pressing matter, Nacy says that developing diagnostic tools for MAP is another urgent priority because there are no reliable ways of identifying or cultivating MAP. Without these tools, determining whether an individual is infected with MAP is very difficult. This deficit is a "conspicuous and fundamental barrier" to progress in research, and it stands in the way of discovering the causes and cures for Crohn's, according to the report. Thus, its authors urge that investigators collaborate to establish reproducible, standardized techniques for detecting MAP.
The AAM report is available electronically and can be ordered by sending an e-mail request to colloquia @asmusa.org.
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Time-Lapse Microscopy Portrays Microsporidia Invading Host Cells
The microsporidium Encephalitozoon cuniculi, an obligate intracellular, opportunistic pathogen, occupies a special compartment within the cytoplasm of host cells called the parasitophorous, or parasite-carrying, vacuole (PV). As for many other intracellular pathogens, the PV vacuole that is associated with E. cuniculi derives from host cell membranes, according to Wolfgang Bohne and colleagues from the University of Gottingen, Germany, whose research findings appear in the June Eukaryotic Cell (7: 1001-1008). These fungi were recently recognized as emerging pathogens that prove particularly threatening for immunocompromised individuals. Although some microsporidia replicate within the cytosol of host cells, the Encephalitozoons, which account for three of the four most common human microsporidian pathogens, are confined to PVs-an intracellular "crash pad" on which various other bacterial and protozoan pathogens also rely. PVs typically derive from the plasma membrane when such microbes enter host cells.
However, before Bohne and his collaborators conducted their studies, some investigators doubted that PVs associated with E. cuniculi derived from that same host source. For one thing, E. cuniculi infect host cells in a highly specialized way, via spores that possess a coiled hollow tube, which other investigators described as extruding suddenly and then quickly injecting its contents into host cells. Because this process happens so quickly, researchers found it difficult to imagine how PVs form.
In trying to solve this puzzle, Bohne and his collaborators labeled host cell plasma membranes with fluorescent tracers. They soon observed that, despite the speed with which the E. cuniculi microsporidia could break into host cells, newly formed PVs contain these tracers. "This raises, of course, the question • Early in June, FDA officials warned U.S. consumers not to eat raw red plum, red Roma, and red round tomatoes, or products containing them because of an outbreak of salmonellosis caused by Salmonella serotype Saint Paul; by late June, although the source of that contaminant remained unknown, the outbreak had spread widely, affecting individuals in 32 states and the District of Columbia.
• Although U.S. and South Korean officials appeared to agree in late June on terms to allow imports of U.S. beef into S. Korea, protesters in Seoul were continuing to express concerns over the risk of bovine spongiform encephalopathy, or mad cow disease; protests on this issue a few weeks earlier led President Lee Myung-bak to shake up and replace many members of his Cabinet. In a speech, he promised to "use this incident as an opportunity to take exhaustive measures to guarantee watertight food safety." about the mechanism that leads to PV formation," he says.
"According to the current infection model, the tip of the hollow tube is penetrating the host cell plasma membrane, and the sporoplasma is directly injected into the host," Bohne continues. However, time-lapse fluorescence microscopy images challenge this model. Instead, they show that a channel-like invagination of the host cell plasma membrane just where the tube is extruded. Within less than 1.3 seconds, the PV membrane is formed.
"These images would better fit an infection model in which the tip of the tube is not penetrating the host cell plasma membrane, but forces the membrane to form a channel-like invagination in which the sporoplasma is injected, and which then might pinch off to form the PV," Bohne says. "However, this model is hypothetical and needs further confirmation."
The researchers also showed, using microinjection of fluorescent dyes, that the PV membrane contains pores, providing the microsporidial pathogens with access to metabolites within the host cell, presumably explaining how E. cuniculi can thrive despite its own metabolic pathways being severely truncated.
"This is the first demonstration of the nature of the PV membrane in this pathogenic organism," says Louis Weiss of Albert Einstein College of Medicine, Bronx, N.Y. "It raises issues about the nature of nutrient acquisition and interactions with the host cell." Weiss notes that "microsporidia modify host cells extensively," by packing them with spores and developing microsporidia. "The paper lays the framework for methods to study the PV membrane in this pathogen," he says. "These results also suggest that the polar tube has specific interactions with the host cell membrane that facilitate development of the PVM."
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NASA Phoenix Lander Seeking Possible Martian Microbial Habitats
After a journey of 422 million miles and nearly 10 months, the Phoenix Lander touched down safely on the northern plains of Mars late last May. The $457-million mission carries a host of scientific instruments designed to answer whether Martian soils could support microbial life. Among the firsts on the mission is a robotic arm for scooping samples of Martian soil for delivery to onboard instruments for analysis. Instruments aboard the lander include the first equivalent of a "wet" chemistry laboratory sent to another planet. This miniature apparatus will provide information on pH and ions such as chlorides, bromides, calcium, potassium, and magnesium. Also included are an optical microscope capable of resolving features that are 2 m across and an atomic force microscope for recording particles as small as 100 nm. Moreover, the Phoenix has a Thermal Evolved Gas Analyzer (TEGA) combined with a mass spectrometer for heating samples to 1,000°C and then detecting and characterizing any traces of hydrocarbon molecules in them.
Ironically, although the Phoenix Lander can analyze conditions that might be conducive for microbial life on Mars, it is not equipped with instruments to detect microorganisms or their metabolites. "Some press articles have misinterpreted our search for biohabitability and chemical signatures as 'looking for life,'" says Samuel Knounaves, who is lead scientist
Progress Sought on Several Vaccine Fronts
Experts are seeking progress on several active but frustrating vaccine research fronts, including:
• Mymetics of Nyon, Switzerland, is reporting progress in early-phase clinical trials in Europe and Africa evaluating its experimental malaria vaccine, which is reported to induce an antibody response that persists threefold longer than other vaccines against the malaria parasite; it is designed to interfere with the sporozoite and merozoite stages of the parasite, and virosomes are used as an adjuvant to boost immunogenicity.
• Barry J. Marshall of the University of Western Australia recently disclosed plans to begin clinical testing of an experimental vaccine, based on a genetically modified form of Helicobacter pylori, as a means for protecting against influenza virus, as well as other infectious diseases; the vaccines are under development at Ondek Ltd. of Subiaco, Western Australia.
• In the aftermath of disappointing clinical trials involving experimental vaccines against HIV, officials at the National Institute of Allergy and Infectious Diseases recently launching a program to study how B cells produce antibodies with the capacity to neutralize HIV; the $15.6-million, five-year program will support 10 research teams in efforts that could help eventual vaccine development.
for the wet chemistry experiments on this mission. Looking for organics is "not looking for life." Nonetheless, finding indigenous organic molecules on Mars could help in settling an unresolved issue raised following the twin Viking Lander missions to Mars in 1976. They were equipped with biological modules and gas chromatograph mass spectrometers (GCMS) to search for evidence of life. Although some readings made it appear as if metabolism were taking place, the GCMS analysis did not register even traces of organic molecules-leading NASA scientists to conclude that they had not detected evidence of life on Mars. Instead, NASA scientists thought then that hydrogen peroxide or some other oxidizing agent in the Martian atmosphere was "bleaching away" any organics that might be in the uppermost soil layers of Mars, explaining some of the "metabolism-like" readings from the biology instruments.
The wet chemistry module on Phoenix is designed to detect organic molecule-destroying oxidants, including hydrogen peroxide. Moreover, TEGA will help in rendering a verdict as to whether Mars has indigenous organic molecules. This instrument is about 100 times more sensitive to organic material than was the Viking GCMS. Moreover, the Viking GCMS could heat samples of Martian soil only to 500°C, not high enough to liberate or detect many types of organic molecules.
During June, July, and August of this year the robotic arm on Phoenix is expected to deliver a series of Martian soil samples to onboard instruments for analysis. However, results of those analyses are not expected until many months later, according to project scientist Peter Smith, who is unsure what to expect. "One possibility is to repeat the Viking results with a greater accuracy and conclude that organics do not exist," he says. "The other end of 
Bdelloid Rotifers Show Surprisingly High Levels of Horizontal Gene Transfers
Bdelloid rotifers, which are asexual, microscopic freshwater invertebrates, show evidence of surprisingly high levels of horizontal gene transfers, including from bacteria, fungi, and plants, according to Eugene Gladyshev and Matthew Meselson of Harvard University in Cambridge, Mass., and Irina Arkhipova of the Marine Biological Laboratory in Woods Hole, Mass. While horizontal gene transfer is considered common in bacterial species, it is unexpected, particularly at this relatively high level, for members of the animal kingdom, the researchers point out. However, Arkhipova says, "Bdelloids may have the capacity for tapping into the entire environmental gene pool, which may be of adaptive significance during expansion into new ecological niches, and may even contribute to bdelloid speciation." These organisms, which can withstand desiccation as well as high levels of ionizing radiation, might be scavenging foreign genes while recovering from such environmentally imposed stresses, the researchers speculate. Details appear in the 30 May issue of Science. 
